Category Archives: CBD

CBD and FDA – Where Are We?

Posted on October 31, 2019 by Mark Senak

Last week FDA and FTC jointly issued a warning letter to a seller of CBD products in Florida – the seventh such warning letter of the year. The letter took issue with the manufactuer’s marketing practices related to multiple products … Continue reading →

Posted in CBD, FDA Policy | Comments Off on CBD and FDA – Where Are We?

FDA Sends CBD Related Warning Letter

Posted on July 25, 2019 by Mark Senak

This week FDA sent a Warning Letter to a company engaged in marketing products containing cannabidiol (CBD) to consumers for a wide variety of uses in both humans and canines. In addition to the letter, the agency underscored their action … Continue reading →

Posted in CBD, FDA Policy, Warning Letters | Comments Off on FDA Sends CBD Related Warning Letter